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Background: The DECIDE framework was developed to support evidence-informed health system decisions
through evidence summaries tailored to health policymakers. The objective of this study was to determine
policymakers’ perceptions regarding the criteria in the DECIDE framework and how best to summarise and present
evidence to support health system decisions.
Methods: We conducted an online survey of a diverse group of stakeholders with health system decision
experience from 15 countries and the World Health Organization. We asked about perceptions of criteria relevant to
making health system decisions, use of evidence, grading systems, and evidence summaries.
Results: We received 112 responses (70% response rate). Most respondents had healthcare (85%) and research
(79%) experience. They (99%) indicated that systematic consideration of the available evidence would help to
improve health system decision-making processes and supported the use of evidence from other countries (94%)
and grading systems (81%). All ten criteria in the DECIDE framework were rated as important in the
decision-making process. Respondents had divergent views regarding whether the same (38%) or different (45%)
grading systems should be used across different types of health decisions. All components of our evidence
summary were rated as important by over 90% of respondents.
Conclusions: Survey respondents were supportive of the DECIDE framework for health system decisions and the
use of succinct summaries of the estimated size of effects and the quality of evidence. It is uncertain whether the
findings of this survey represent the views of policymakers with little or no healthcare and research experience.
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Decisions regarding health systems are often political
processes involving a number of policymakers and other
key stakeholders. There is a need to support these deci-
sions with the best available evidence, however, the
effects of health system interventions are often uncer-
tain and stakeholders may have a low level of medical
and research literacy. The Developing and Evaluating* Correspondence: oxman@online.no
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reproduction in any medium, provided the orCommunication Strategies to Support Informed Decisions
and Practice Based on Evidence (DECIDE) project is a
collaborative research project funded by the European
Commission’s Seventh Framework Programme [www.de-
cide-collaboration.eu]. The project’s objective is to develop
and evaluate communication strategies to support evidence-
informed decisions by building on the work of the Grading
of Recommendations Assessment, Development, and Evalu-
ation (GRADE) Working Group [www.gradeworkinggroup.
org] and the Cochrane Applicability and Recommenda-
tions Methods Group [www.armg.cochrane.org]. As part
of the DECIDE project, we have developed a frameworktd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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health systems [http://www.decide-collaboration.eu/WP5/
Strategies/Framework].
The development of this framework was informed by
our earlier work on plain language summaries of system-
atic reviews [1] and work on evidence-based policy briefs
[2-4]. The framework includes relevant criteria for mak-
ing health system decisions as well as evidence to inform
judgements about each criterion. The criteria included
in the framework are seriousness of the problem, num-
ber of people affected, quality of the evidence, size of the
benefits, size of the adverse effects, resource use (costs),
value for money, impacts on equity, implementability
(feasibility), and acceptability. These framework criteria
emerged from a literature review, brainstorming, feed-
back from stakeholders, and application of the frame-
work to examples. This survey, along with user testing
and further application of the framework to health sys-
tem decisions, will further inform the selection of cri-
teria included in the framework and how they are
presented.
There are several different systems available to grade
the quality of evidence on the effects of healthcare inter-
ventions. Most of these have been used primarily for
clinical practice guidelines and those systems have be-
come increasingly similar to GRADE or replaced by
GRADE [5-7]. Other systems have been used for popula-
tion health guidelines (primarily for public health rather
than health system interventions), such as the systems
used by the Task Force on Community Preventive Ser-
vices [6,8,9], although the GRADE system is also used
for public health and health system recommendations
[10,11]. All of these grading systems have focused pri-
marily on grading the quality of evidence and only to a
lesser extent, if at all, on frameworks for going from evi-
dence to public health or health system decisions or
recommendations.
The use of grading systems for rating the quality of
evidence is seen as essential for evidence-based guideline
development. The GRADE methodology has been
adopted by WHO, as well as by national guideline devel-
opers and others to assess the quality of evidence in
guideline development as it enables a comprehensive,
transparent and structured analysis of available litera-
ture, whilst clearly communicating the quality of evi-
dence and strength of the recommendations [1,12,13].
However, there is considerable debate as to whether the
same approach to grading evidence for clinical decisions
should also be used for health system decisions. Advo-
cates for the use of the same grading system for both
types of decisions state it can minimise confusion, re-
duce the risk of bias, and maintain transparency and
consistency across different types of decisions. Critics
state that a rating system that is appropriate for clinicalinterventions may not discriminate evidence in a way
that is appropriate for health system programmes or pol-
icies, potentially disadvantaging effective interventions
that are not amenable to randomized controlled trials [10].
The presentation of evidence to inform health system
decisions requires the development of summaries that
can 1) communicate complex information in plain lan-
guage; 2) clearly present the anticipated effects and the
certainty (quality) of the underlying evidence; and 3) ef-
fectively convey uncertainty. We have previously devel-
oped and user-tested evidence summaries tailored for
health policymakers in low- and middle-income coun-
tries [2], built on earlier findings for Cochrane reviews
[14,15]. An evidence summary based on the DECIDE
framework needs to clearly communicate evidence relat-
ing to each of the ten DECIDE framework criteria, in-
cluding the effect sizes and quality of evidence available
for the anticipated desirable and undesirable effects of
the intervention being considered. The design of these
evidence summaries to support policymakers’ under-
standing of evidence therefore requires a detailed ana-
lysis of their perceptions of certainty (quality) of the
evidence and how it is assessed.
To obtain a better understanding of policymakers’,
managers’ and other stakeholders’ perceptions of the cri-
teria for health system decisions in the DECIDE frame-
work, and how evidence on these should be presented,
we conducted an international online survey. The survey
focused on stakeholders’ perceptions of each of the ten
DECIDE framework criteria, the grading of health sys-
tem evidence, and the use of evidence summaries. This
paper aimed to collect information regarding the experi-
ence and perceptions of participants with respect to the
proposed criteria, assessments of the quality of evidence
used to inform judgements about the effects of interven-
tions, and summaries of research evidence of the effects
of health system interventions.
Methods
We conducted an international online survey to deter-
mine perceptions of the importance and use of the cri-
teria within the DECIDE framework and evidence
summaries. We aimed to survey a diverse (rather than
representative) group of policymakers from different
countries, with a wide range of experience with different
types of health policy and management decisions and
with different perspectives. Our sampling frame included
the nine DECIDE partner countries (Canada, England
and Wales, Finland, Germany, Italy, the Netherlands,
Norway, Scotland, and Spain), the World Health
Organization (WHO), and six SURE (Supporting the
Use of Research Evidence for policy in African health
systems) partner countries, namely Cameroon, Ethiopia,
Mozambique, Zambia, Uganda, and South Africa [www.
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tive research project with the objective of developing
and evaluating strategies for improving access to and use
of research evidence in health policy development in
Africa. These countries were included as we had suffi-
cient networks linked to the DECIDE and SURE projects
to provide the necessary referrals to potential partici-
pants. Inclusion criteria for survey participants included
people responsible for health system decisions and
stakeholders with an interest in and experience with
health system decisions, such as delivery, governance
and financial arrangements, and strategies for
implementing health system changes. This could include
public officials, managers, health workers, and represen-
tatives of special interest groups, international organiza-
tions, non-governmental organisations, donor countries,
or the general public. Our partners in the DECIDE and
SURE projects from each country and other personal
contacts helped us to identify 10 to 20 people who were
not involved with the DECIDE collaboration in each of
the 15 countries and within WHO, with the aim of
obtaining 10 completed questionnaires from each. We
prepared an online survey (in English only) using the
LimeService online platform [https://www.limeservice.
com/] (Additional file 1 Table S1). The survey was re-
vised after pilot testing in a small group of policymakers
who provided feedback on the content, length, clarity,
and ease of use. Informed consent was obtained from
survey participants prior to commencing the survey and
results were de-identified when exported for analysis to
protect confidentiality.
To determine current use and perceived importance of
the DECIDE criteria in health system decision-making,
we asked participants to provide an example of a health
system decision with which they had been involved or
were familiar. Participants were asked to rate whether
each of the ten criteria in the DECIDE framework (ser-
iousness of the problem, number of people affected,
quality of available evidence, benefits (desirable effects),
adverse (undesirable) effects, resource use (cost), value
for money, impacts on equity, implementability (feasibil-
ity), and acceptability) had been considered as part of
this healthcare decision on a 3-point scale (yes, no, un-
sure). If a given criterion had not been considered, they
were asked whether they considered it relevant, and also
to state any other criteria they considered relevant. The
opportunity to make optional comments was provided.
Participants were also asked to rate the importance (im-
portant, probably important, not sure, probably not im-
portant, not important) of each of the ten criteria, with
optional comments if desired.
To determine perceptions on the use of evidence in
health system decisions, we asked participants about
their use of 1) evidence from other countries; 2)systematic reviews to inform their health system deci-
sion; and 3) evidence grading systems. Specifically, we
asked whether they believed that evidence grading sys-
tems should be the same or different for health system
decisions, compared to clinical decisions. We also
assessed the perceptions of participants as to the con-
tents of summaries of evidence. These summaries, based
on the best available evidence, should be concise yet in-
clude all of the key information needed to inform a
health system decision. We asked participants to rate
the importance of including certain types of information
(components) in these summaries, namely: effect sizes,
confidence intervals, numbers of studies, and the quality
of the evidence. Participants also provided information
on their research, healthcare, and decision-making
experience.
Participants were contacted by email and asked to
complete the online survey. Initial contacts were made
by our partners in each country or directly by us. Non-
responders received reminders via email at two and four
weeks after the initial invitation. We summarised the re-
sults using frequencies and percentages, and collated
provided comments. Our primary analysis focused on
implications for our evidence to health system decisions
framework and evidence summaries. We explored po-
tential differences in responses across participants from
different countries (DECIDE versus SURE partner coun-
tries) and across groups with different types of experience
(with versus without research training or experience).Results
We received 112 responses (70% response rate) to the
online survey. Of these, 84 responses (75%) were
complete and 28 (25%) were partially complete. We re-
ceived 23 responses (46% response rate) from the six
SURE countries, 84 responses (93% response rate) from
the nine DECIDE partner countries, and five responses
(50% response rate) from WHO. Table 1 describes the
characteristics of survey participants who provided back-
ground information (n = 84). Most (84.5%) of the re-
spondents had healthcare professional training or had
worked as a healthcare professional. The majority of
these were physicians (87.1%), and most (69.0%) had
over ten years clinical experience. Most (78.6%) also had
some form of research training or experience; 54.5% of
these had over ten years of research experience. Respon-
dents had worked in a variety of organizations, most fre-
quently in national governments (63.1%) and public
organizations (48.8%). The most common forms of health
system decisions made or supported by respondents were
decisions regarding the selection of healthcare policies, re-
forms or programmes (77.4%), and decisions on their im-
plementation (78.6%).
Table 1 Characteristics of survey participants
Survey participants, n (%)
Total (completed entire survey) 84 (75.0)
No healthcare professional training or experience working as a healthcare professional 13 (15.5)





Years of experience as healthcare professional
1 – 10 years 22 (31.0)
11 – 20 years 18 (25.4)
21 – 30 years 14 (19.7)
31 – 40 years 14 (19.7)
40+ years 3 (4.2)
Research training or experience working as a researcher 66 (78.6)
MSc or equivalent 24 (36.4)
PhD or equivalent 40 (60.6)
Other 2 (3.0)
Years of experience as a researcher
1 – 10 years 30 (45.5)
11 – 20 years 20 (30.3)
21 – 30 years 12 (18.2)
31 – 40 years 3 (4.5)
40+ years 1 (1.5)
Levels of current and previous work*
International governmental organization 15 (17.9)
National government 53 (63.1)
Regional government 26 (31.0)
Local government 18 (21.4)
Public organization 41 (48.8)
Private organization 16 (19.1)
Other 19 (22.6)
Types of health system decisions supported
Experience representing the views of stakeholders in policy or management processes 46 (54.8)
Decisions about healthcare policies, reforms or programmes 65 (77.4)
Decisions about implementation of healthcare policies, reforms or programmes 66 (78.6)
Management decisions about health system arrangements 44 (52.4)
Decisions about quality improvement, patient safety or implementation of clinical guidelines 56 (66.7)
Other 5 (6.0)
*These categories were not mutually exclusive and hence the sum is greater than 100%.
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decision with which they had been involved or had the
opportunity to follow closely. One hundred and two re-
spondents (91.1%) had such an example and 10 (8.9%)
respondents imagined a current or recent decision. Figure 1
shows their responses regarding whether our criteria wereconsidered for their health system decisions. Over 75% of re-
spondents stated they had considered these criteria in their
decision, except for value for money (67%) and impacts on
equity (70%). Comments were infrequent but almost univer-
sally in support of the need to consider these criteria and
the lack of evidence on certain criteria, such as equity and
Figure 1 Survey responses regarding criteria considered for individual health system decisions.
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dents indicated that consideration of these criteria is
mandatory for decisions taken in their organization. Most
(86.4%) of the respondents had considered evidence from
other countries for their decision, and 94.3% of respondents
agreed or somewhat agreed that evidence from other coun-
tries should be used to inform health system decisions. Most
(90.9%) of the respondents stated they knew what a system-
atic review was. However, only 60.2% of respondents had
used evidence from a systematic review to inform their deci-
sion. In response to our question on whether systematic
consideration of the available research evidence would helpFigure 2 Survey responses rating the importance of criteria in healthto improve health system decision-making, 98.9% stated it
would or it probably would.
Respondent ratings on the importance of the ten cri-
teria are summarised in Figure 2. Every criterion was
rated as important or probably important by over 90% of
respondents. Nearly all respondents (99.2%) agreed that
explicit consideration of the ten criteria would help or
probably help to improve health system decision-making.
While comments supported the importance of the criteria,
several respondents identified further criteria. These
included sustainability of implemented changes, post-
implementation monitoring systems, human resourcesystem decisions.
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what is occurring in nearby areas or similar jurisdictions).
Most respondents agreed that a system of grading evi-
dence would either definitely (59.7%) or probably
(33.3%) improve health system decision-making pro-
cesses (Table 2). When asked whether such grading sys-
tems should be the same for clinical and health system
decisions, 38.4% said it should or probably should be the
same, 45.3% indicated that different grading systems
should or probably should be used for clinical and health
system decisions, and 16.3% were neutral. This disagree-
ment was also reflected in comments. Some respondents
stated that using the same grading system improves
consistency, transparency, and reproducibility, while
others stated that they are fundamentally different types
of decisions and evidence, requiring different grading
systems. Two respondents (both from DECIDE partner
countries) indicated an overall dislike of evidence grad-
ing systems. Respondent ratings on the importance of
components of a summary of evidence are described in
Figure 3. There was general agreement that all of the
summary components were important or probably im-
portant, ranging from 79% (confidence intervals for ef-
fect estimates) to 96% (description of the quality of the
evidence). All comments were in broad support, includ-
ing several highlighting the need for clarity, simplicity,
and brevity. Others suggested the use of disability-
adjusted life years (DALYs) and number needed to treat
(NNT) as important measures of effect.
Overall, there was relatively little variation in the re-
sponses. Nonetheless, we explored potential differences
in responses across participants from different countries
and across groups with different types of research ex-
perience (Additional file 1 Table S1). We did not findTable 2 Respondents’ views on the use of grading systems to






Do you think that a system for rating the quality of evidence should be
different systems for different types of decisions (e.g., for clinical decis
The SAME SYSTEM DEFINITELY should be used for rating the quality of ev
The SAME SYSTEM PROBABLY should be used for rating the quality of evi
Neutral
A DIFFERENT SYSTEM PROBABLY should be used for rating the quality of
clinical decisions
A DIFFERENT SYSTEM DEFINITELY should be used for rating the quality of
clinical decisionsany apparent differences in responses based on the re-
spondents’ country (DECIDE versus SURE partner coun-
tries) or experience (with compared to without research
training or experience).
Discussion
We received 112 responses to an online survey from a
diverse, international group of policymakers, managers,
their support staff and other stakeholders to better
understand their perceptions of the ten criteria in the
DECIDE framework for going from evidence to health
system decisions. We also obtained their perceptions of
the components of summaries of evidence. Our respon-
dents had a high level of professional healthcare and re-
search experience and training and had worked in a
wide range of levels and organizations. This may be due
to the way in which they were identified, or a greater
interest among those policymakers with clinical or re-
search experience to participate in the survey. Our
sample of policymakers was not intended to be represen-
tative of included countries, but was rather to obtain a
diverse range of views from respondents.
Respondents had generally considered all ten criteria
in the DECIDE framework in their own healthcare deci-
sions and consistently rated these criteria as important
or probably important to decision-making. In earlier
work, Guindo and colleagues identified a range of
healthcare decision criteria and criteria-based decision-
making tools used in empirical studies of health system
decisions – the most frequently cited criteria were equity
and fairness, efficacy/effectiveness, stakeholder interests
and pressures, cost effectiveness, strength of evidence,
and safety [16]. In our survey, comments by respondents









consistent for different types of decisions or that there should be
ions and for health system decisions)?
idence for clinical and health system decisions 9 (10.5)
dence for clinical and health system decisions 24 (27.9)
14 (16.3)
evidence for health system decisions than for 27 (31.4)
evidence for health system decisions than for 12 (13.9)
Figure 3 Survey responses rating the importance of components of a summary of evidence.
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some organizations, their consideration is mandatory.
However, only 60.2% reported using systematic reviews
to inform decision making. This may reflect both a lack
of systematic reviews addressing relevant questions, as
well as other reasons for not using research evidence to
inform health policy decisions, as reported elsewhere
[17,18].
Most respondents agreed that a system of grading evi-
dence would improve health system decisions; however,
there was considerable disagreement as to whether these
grading systems should be uniform across clinical and
health system decisions. This is consistent with the on-
going debate in the literature on the application of the
GRADE approach to a range of decisions [10,12]. While
a common approach to grading evidence may reduce
confusion, minimise conflicts of interest and enhance in-
tellectual rigor, others have argued that this approach
can be overly complex and can favour false negative con-
clusions. Additionally, interventions that are not amen-
able to randomised trials could be disadvantaged in
terms of prioritisation, funding and implementation [12].
Criticisms made by our respondents of a uniform grad-
ing approach concur with the literature that there is a
lack of available high-quality evidence on health system
interventions. Two respondents also indicated an overall
dislike of grading systems, citing a tendency to oversim-
plify complex issues or a lack of institutional capacity to
provide training or support grading activities. However,
the application of some form of systematic consideration
of evidence to support health system decisions hadbroad support in our survey. Successful implementation
of the GRADE approach for health system decision-
making will need to address concerns about its applic-
ability to health system evidence.
Effectively communicating complex information through
summaries has been proven in the use of the GRADE sum-
mary of findings table [13,19] and SUPPORT summaries [2].
SUPPORTsummaries summarise the best available evidence
of the effects of health system interventions for low and
middle-income countries. Such summaries may be particu-
larly useful for policymakers without a strong health or re-
search background. Although our respondents had a
higher-than-expected level of healthcare and research ex-
perience, their responses clearly indicated that all pro-
posed components of the summaries of evidence have
practical applications in health system decision processes.
Comments strongly favoured clear, concise summaries in
simple language, suggesting that researchers should con-
sider ease of interpretation by policymakers with limited
scientific literacy when preparing summaries.
The strengths of this survey were a good response rate
from a diverse range of countries, backgrounds, levels of
decision-making, and organisations. The fact that 25% of
the surveys were partially completed may have been due
to survey length. The comparatively lower response rate
from SURE partner countries means results are likely
biased towards higher-resource settings, limiting their
applicability to resource-constrained settings. One sig-
nificant limitation of the survey was the relatively high
level of healthcare and research experience amongst re-
spondents; only four respondents had no healthcare or
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of health policymakers in general and potentially limits
the generalizability of our findings. Nonetheless, the fact
that the criteria included in the DECIDE framework
were regarded as important for decision-making by these
respondents provides further support for their inclusion
in a framework for going from evidence to health system
decisions.
This survey confirmed the relevance of the criteria that
we had identified and incorporated in the DECIDE frame-
work for health system decisions and suggests that the
framework is likely to be helpful for informing health sys-
tem decisions. Further development and evaluation of the
framework will be based on practical applications of the
framework to health system and population health deci-
sions and user testing [20]. Facets of the framework that
will be addressed by user testing were adapted from the
work by Morville et al. [21] and Rosenbaum et al. [22],
and include 1) findability: can users locate what they are
looking for?; 2) usefulness: does the framework have prac-
tical value for the user?; 3) usability: how easy and satisfy-
ing is the framework to use?; 4) understandability: do
users understand the framework and the content cor-
rectly?; 5) credibility: is this framework/content trust-
worthy?; 6) desirability: is the framework something the
user wants/responds positively to?; and 7) identification:
does the framework feel like it was designed for “someone
like me (the user)”? Further work will address the advan-
tages and disadvantages of using the same versus different
systems for grading evidence, further clarification of the
included criteria, the need for additional criteria, and the
perceptions of policymakers and stakeholders who do not
have a research or health professional background.
Conclusions
Health system decision-making requires careful consid-
eration of a multitude of variables, such as the magni-
tude of the problem, the size of benefits and adverse
effects, feasibility and acceptability, as well as resource
and equity implications. Surveyed individuals supported
the use of systems to grade the quality of evidence for
health system decisions, but there was disagreement as
to whether uniform or different grading systems should
be used for health system and clinical decisions. Com-
munication of evidence to policymakers and stake-
holders involved in health system decisions should
employ succinct summaries of measures of effect and
the quality of evidence in clear and simple language.
Additional file
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evidence and components of evidence summaries, stratified by research
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none were significant at the P <0.05 level.
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